Dana Mathews: Clinical Trials

2 trials sponsored by Dana Mathews, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1

Follow Dana Mathews: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer
68Ga PSMA-11 injection, Positron Emission Tomography/Computed Tomography - Prostate Cancer, Prostate Cancer Metastatic
Phase 2WithdrawnDana Mathews2021-03-192023-05-19
The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer
68Ga PSMA-11 injection, Positron Emission Tomography/Computed Tomography - Prostate Cancer, Prostate Cancer Metastatic
Phase 2CompletedDana Mathews202020-01-272023-03-20

Conditions studied

Prostatic Neoplasms (2)

Interventions

Magnetic Resonance Spectroscopy (2)  ·  gallium 68 PSMA-11 (2)

Countries

United States (2)

Top investigators

Orhan K Oz, MD, PhD (2)

Results publications

PMID 41077599